Xoma | XOMA - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
AbbVie USD 4.38B 1.92B 2025-09
Agenus USD -10.61M 263.52M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Ardelyx USD -400K 467K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Curis USD 19.36M 33.34M 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Incyte USD 389.94M 92.37M 2025-12
MacroGenics USD -14.93M 31.75M 2025-12
Novartis USD 4.64B 445M 2025-12
Novartis USD 5.17B 637M 2025-09
Pfizer USD 3.33B 290M 2025-09
Prothena USD -21.58M 15.33M 2025-12
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Xoma USD 15.98M 24.58M 2024-06